
Sign up to save your podcasts
Or
Special panel edition of the Amplifying Scientific Innovation Video Podcast that will focus on innovative approaches for optimizing clinical trial diversity during the JP Morgan Healthcare Conference, which is the largest and most informative healthcare investment symposium in the industry. Moderated by Dr. Sophia Ononye-Onyia, Founder and CEO, The Sophia Consulting Firm. Panel lineup: • Dr. Craig Tendler, VP of Clinical Development and Global Medical Affairs, Oncology at Janssen Research and Development, LLC , one of the Janssen Pharmaceutical Companies of Johnson & Johnson. • Mr. Brian Loew is the CEO of Inspire. • Ms. Kimberly Richardson is a seven year survivor of ovarian cancer who was recently diagnosed with triple-positive breast cancer. • Dr. Carmen Guerra is an Associate Professor of Medicine, Vice Chair of Diversity and Inclusion in the Department of Medicine and Associate Director of Diversity and Outreach at the Abramson Cancer Center (ACC) at the Perelman School of Medicine, Penn . • Dr. Del Smith is the co-founder and CEO of Acclinate.
5
33 ratings
Special panel edition of the Amplifying Scientific Innovation Video Podcast that will focus on innovative approaches for optimizing clinical trial diversity during the JP Morgan Healthcare Conference, which is the largest and most informative healthcare investment symposium in the industry. Moderated by Dr. Sophia Ononye-Onyia, Founder and CEO, The Sophia Consulting Firm. Panel lineup: • Dr. Craig Tendler, VP of Clinical Development and Global Medical Affairs, Oncology at Janssen Research and Development, LLC , one of the Janssen Pharmaceutical Companies of Johnson & Johnson. • Mr. Brian Loew is the CEO of Inspire. • Ms. Kimberly Richardson is a seven year survivor of ovarian cancer who was recently diagnosed with triple-positive breast cancer. • Dr. Carmen Guerra is an Associate Professor of Medicine, Vice Chair of Diversity and Inclusion in the Department of Medicine and Associate Director of Diversity and Outreach at the Abramson Cancer Center (ACC) at the Perelman School of Medicine, Penn . • Dr. Del Smith is the co-founder and CEO of Acclinate.